Structures by: Vicentes D. E.
Total: 15
1-Phenylisochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H9N3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.6814(5)Å b=6.4310(3)Å c=16.0589(8)Å
α=90° β=100.687(2)° γ=90°
1-(2-Methylphenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C16H11N3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=7.5676(5)Å b=20.2663(14)Å c=9.2503(7)Å
α=90° β=112.957(3)° γ=90°
1-(3-Chlorophenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H8ClN3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.0993(8)Å b=12.8996(9)Å c=9.2234(6)Å
α=90° β=106.675(2)° γ=90°
1-(4-Chlorophenyl)isochromeno[3,4-<i>d</i>][1,2,3]triazol-5(1<i>H</i>)-one
C15H8ClN3O2
Acta Crystallographica Section C (2020) 76, 5 446-453
a=16.7331(12)Å b=5.9676(4)Å c=13.6810(10)Å
α=90° β=112.820(3)° γ=90°
Methyl 2-[4-hydroxy-1-(2-methylphenyl)-1<i>H</i>-1,2,3-triazol-5-yl]benzoate
C17H15N3O3
Acta Crystallographica Section C (2020) 76, 5 446-453
a=11.1518(5)Å b=9.3143(4)Å c=14.2417(6)Å
α=90° β=98.655(2)° γ=90°
<i>N</i>^4^-(2-Aminophenyl)-6-methoxy-5-nitrosopyrimidine-2,4-diamine
C25H22N6O
Acta Crystallographica Section C (2019) 75, 10
a=9.7167(10)Å b=16.1179(17)Å c=13.9936(16)Å
α=90° β=91.395(4)° γ=90°
6-Methoxy-<i>N</i>^5^-(4-methoxybenzyl)-4-[2-(4-methoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C27H26N6O3
Acta Crystallographica Section C (2019) 75, 10
a=15.8911(13)Å b=9.6209(7)Å c=15.9244(11)Å
α=90° β=91.581(3)° γ=90°
6-Methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine monohydrate
C19H18N6O,H2O
Acta Crystallographica Section C (2019) 75, 10
a=8.1992(7)Å b=11.0160(8)Å c=11.4240(9)Å
α=109.105(3)° β=109.171(3)° γ=97.138(3)°
6-Methoxy-<i>N</i>^5^-(4-nitrobenzyl)-4-[2-(4-nitrophenyl)-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl]pyrimidine-2,5-diamine
C25H20N8O5
Acta Crystallographica Section C (2019) 75, 10
a=7.6614(6)Å b=16.6048(11)Å c=18.1311(13)Å
α=90° β=97.101(3)° γ=90°
<i>N</i>-{2-Amino-6-methoxy-4-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-5-yl}-2,2,2-trifluoroacetamide
C21H17F3N6O2,CH4O
Acta Crystallographica Section C (2019) 75, 10
a=12.6296(8)Å b=11.2206(7)Å c=15.6480(10)Å
α=90° β=104.180(2)° γ=90°
<i>N</i>-{5-Amino-6-methoxy-6-[2-(4-methylphenyl)-1<i>H</i>-\ benzo[<i>d</i>]imidazol-1-yl]pyrimidin-2-yl}-2,2,2-trifluoroacetamide ethyl acetate monosolvate
C21H17F3N6O2,C4H8O2
Acta Crystallographica Section C (2019) 75, 10
a=9.1818(8)Å b=21.0771(16)Å c=13.3610(11)Å
α=90° β=91.777(3)° γ=90°
<i>N</i>^4^-{2-[(Ethoxymethylidene)amino]phenyl}-6-methoxy-5-nitrosopyrimidine-2,4-diamine dimethyl sulfoxide monosolvate
C14H16N6O3,C2H6OS
Acta Crystallographica Section C (2018) 74, 6
a=10.8498(11)Å b=17.2238(15)Å c=11.3806(11)Å
α=90° β=115.351(3)° γ=90°
6-Methoxy-<i>N</i>^4^-{2-[(4-methylbenzylidene)amino]phenyl}-5-nitrosopyrimidine-2,4-diamine dimethyl sulfoxide monosolvate
C19H18N6O2,C2H6OS
Acta Crystallographica Section C (2018) 74, 6
a=10.801(5)Å b=17.301(8)Å c=11.777(7)Å
α=90° β=104.28(2)° γ=90°
3-Amino-4-anilino-1<i>H</i>-isochromen-1-one
C15H12N2O2
Acta Crystallographica Section C (2013) 69, 7 770-773
a=10.157(2)Å b=5.7147(5)Å c=21.208(3)Å
α=90.00° β=105.048(15)° γ=90.00°
3-Amino-4-[methyl(phenyl)amino]-1<i>H</i>-isochromen-1-one
C16H14N2O2
Acta Crystallographica Section C (2013) 69, 7 770-773
a=14.5018(15)Å b=7.7796(8)Å c=11.608(2)Å
α=90.00° β=95.728(13)° γ=90.00°